These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3140447)

  • 1. Trypanosoma cruzi infection in diabetic mice.
    Tanowitz HB; Amole B; Hewlett D; Wittner M
    Trans R Soc Trop Med Hyg; 1988; 82(1):90-3. PubMed ID: 3140447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denervation and the immune response in mice infected with Trypanosoma cruzi.
    Ribeiro dos Santos ; Hudson L
    Clin Exp Immunol; 1981 May; 44(2):349-54. PubMed ID: 6796312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
    Kim MJ; Kim HK
    Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
    Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM
    Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
    Trischmann TM
    J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of cell-mediated immunity in mutation diabetic mice (db/db).
    Mandel MA; Mahmoud AA
    J Immunol; 1978 Apr; 120(4):1375-7. PubMed ID: 347001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: transfer of resistance to Brazil strain challenge with lymphocytes.
    Rowland EC; Ritter DM
    J Parasitol; 1984 Oct; 70(5):760-6. PubMed ID: 6439846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
    Carneiro CM; Martins-Filho OA; Reis AB; Veloso VM; Araújo FM; Bahia MT; de Lana M; Machado-Coelho GL; Gazzinelli G; Correa-Oliveira R; Tafuri WL
    Acta Trop; 2007 Feb; 101(2):120-9. PubMed ID: 17296162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
    Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
    Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1985 Apr; 71(2):183-91. PubMed ID: 3923183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of clones of the Brazil strain of Trypanosoma cruzi.
    Murfin DJ; Choromanski L; Kuhn RE
    J Parasitol; 1985 Oct; 71(5):525-9. PubMed ID: 3932632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.
    Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV
    Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term isografts of cultured fetal mouse pancreatic islets. The oncogenic effects of streptozotocin and the prevention of diabetic renal complications.
    Mandel TE; Hoffman L; Carter WM
    Am J Pathol; 1981 Sep; 104(3):227-36. PubMed ID: 6457532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.